Objectives. To describe disparities in HIV infection and syphilis among gay, bisexual, and other men who have sex with men (MSM) in US states through ratio-based measures and graphical depictions of disparities.
R acial/ethnic disparities in sexually transmitted infections (STIs) among gay, bisexual, and other men who have sex with men (MSM) have existed since at least early in the HIV epidemic. Disparities arise for complex reasons, including structural factors, 1 and infectious disease disparities are often interwoven with complex and broader patterns of health disparities (i.e., syndemics). 2 In the United States, an important national prevention goal is reducing disparities in new diagnoses of HIV among MSM and young Black and African American (hereafter "Black") MSM by at least 15% by 2020. 3 National goals are critical aspirational targets and important for setting national policies and priorities but will only be achieved as racial/ ethnic disparities in HIV and other STIs are mitigated in local settings. Although disparities are well understood nationally, understanding how racial/ethnic disparities play out in specific states is an important step in achieving national goals for reducing disparities. Developing state-specific estimates of race-specific rates and disparities also allows the visualization of data in novel ways that might help increase insights into the patterns of disparities in US states.
HIV and syphilis affect non-Hispanic Black and Hispanic people (note that Hispanic people may self-categorize along a continuum that includes Black, White, and other races) to a degree that is disproportionate to their presence in the population. 4 Blacks make up more than 12% of the US population but accounted for 44% of HIV diagnoses and 29% of the new primary and secondary (P&S) syphilis infections in 2016. Latinos make up 17% of the population and accounted for 25% of HIV diagnoses and 20% of new P&S syphilis infections in 2016. 5, 6 HIV and syphilis are related in terms of susceptible populations, behavioral risks, and biology. Thus, HIV and syphilis are often linked when considering sexual health outcomes among MSM. Syphilis causes inflammatory genital ulcers and lesions that can increase the risk of HIV transmission. 7 A syphilis infection can also cause an increase in viral load for someone who is living with HIV. 8 The disparities among minority MSM in both HIV and syphilis can be partly attributed to various social determinants of health. 9 Kelley et al. found that high sexual network prevalence of HIV, increased poverty rates, and lack of access to medical care lead to disparities in HIV and other STIs among Black MSM. To better describe the pattern of disparities in HIV infection and syphilis among MSM in the United States, we used state-level surveillance data of reported HIV and syphilis cases and state-level estimates of MSM population sizes derived from a small area estimation method. 16 We used these data sources to provide estimates of HIV and syphilis prevalence for US states by race and derived prevalence ratios as a measure of disparities in HIV and syphilis. Because rate ratios (RRs) do not directly provide information about the magnitude of rates of diagnoses (ratios only provide information on the relative magnitude), we also used a data visualization approach to allow additional insights into the patterns of disparities.
METHODS
To calculate rates of HIV prevalence, HIV diagnoses, and syphilis diagnoses among MSM by state and race/ethnicity, we first calculated numerators (disease numbers) and denominators (population numbers) by state and race/ethnicity. To examine disparities, we calculated RRs by state, comparing non-Hispanic Black MSM to non-Hispanic White MSM (i.e., HIV prevalence, HIV diagnoses, and syphilis diagnoses) and Hispanic MSM to non-Hispanic White MSM (i.e., HIV prevalence and HIV diagnoses). Because of low syphilis case counts in most states for Hispanic MSM, we have not presented syphilis RRs for Hispanic compared with non-Hispanic White MSM.
HIV and Syphilis
We extracted national and state-level (plus the District of Columbia) counts of persons living with an HIV diagnosis (2015) and those with new HIV diagnoses (2016) among MSM from public Centers for Disease Control and Prevention (CDC) and AIDSVu.org data sources, with de-identified information reported to the CDC by state, county, and local health departments. 17 Health departments' surveillance data include age, race/ethnicity, and transmission category, including male-to-male sexual contact. 18 Data on male-male sex come from a summary of directly reported risk data and imputed risk data. 18 We followed standard publication practices for HIV surveillance data to protect privacy and to ensure stability of rates by suppressing data in states with fewer than 12 diagnoses in a state or subgroup. 16, 18 Suppressed state data contributed to national estimates.
For syphilis, we included new diagnoses of P&S syphilis for MSM by jurisdiction and by race/ethnicity in 2016 as reported to the CDC as part of the National Notifiable Diseases Surveillance System. 19 The CDC directly provided data at this level of stratification, and these data do not appear in any other surveillance reports. Case reports include data on sex and race/ethnicity. Furthermore, jurisdictions record information on the sex of partners-whether male, female, or both male and female-and in 2016, 49 states reported these data to the CDC. 15 We considered men who reported male partners (whether or not they also reported female partners) to be MSM. We suppressed data for states in which data about sex of partners was reported on fewer than 70% of P&S cases, and we excluded 3 states with less than 50% reporting of sex of partners on P&S cases. 15 
Number of Men Who Have Sex With Men by State and Race
Denominator data came from an update to our previously published method that estimated 2016 race/ethnicity-specific numbers of adult MSM in each state and the District of Columbia. 16, 20 Rates of HIV prevalence, HIV diagnoses, and syphilis diagnoses were previously reported through 2014. 21 For rates of HIV diagnoses, we subtracted prevalent cases of HIV from the MSM denominator when calculating rates, because previously diagnosed persons cannot be newly diagnosed.
Rates and Rate Ratios
To calculate RRs, for each state, we took the disease rates previously calculated and divided the rates for non-Hispanic Black MSM by rates for non-Hispanic White MSM and the rates for Hispanic MSM by rates for non-Hispanic White MSM (HIV only). We calculated 95% confidence intervals (CIs) of the RRs overall using a bootstrapping approach that accounted for the random error from the MSM denominators in the numerator and denominator rates. As described earlier, we estimated the race-specific statelevel MSM denominators from formulas that used American Community Survey responses regarding same-sex male households and 2 national estimates of MSM populations. 22 We used the following procedure to account for random error in our ratio estimates: for each of 100 000 simulation runs (1) take a random draw from normal distributions defined by each of these 3 inputs' point estimates and standard errors, (2) recalculate the MSM denominator for each state and race, and (3) merge in diagnosis data and compute RRs. We ranked the resulting 100 000 RRs for each disease and race comparison and used the 2.5th and 97.5th percentiles to construct the 95% CI. 
Data Visualization
To further illustrate the components of the disparity measures, we created race/ ethnicity-specific scatterplots that illustrate the 2 race/ethnicity-specific rates and the summary RRs for HIV (i.e., Black-White, HispanicWhite) and for syphilis (Black-White only). We inspected these plots to identify patterns of race-specific rates and resulting RRs.
RESULTS
In the United States overall, 2016 rates of prevalent HIV diagnoses and new HIV diagnoses were higher for Black than for non-Hispanic White MSM (prevalent: RR = 3.29; new diagnoses: RR = 5.87) and were higher for Hispanic than for nonHispanic White MSM (prevalent: RR = 1.72; new diagnoses: RR = 2.97). In all states with reportable data, the state-specific Black-White and Hispanic-White RRs for HIV diagnoses were greater than 1.0, indicating a disparate impact among MSM of color in recent diagnoses.
Nonetheless, there was substantial heterogeneity in state-specific measures of disparity (Table 1) . For prevalent HIV infections in Black MSM, the highest state-specific disparity was in North Dakota (RR = 7.14), and the lowest was in Hawaii (RR = 1.20). For prevalent HIV infections in Hispanic MSM, the highest state-specific disparity was in Vermont (RR = 5.17), and the lowest was in Hawaii (RR = 0.73; 1 of 2 states with a Hispanic-White RR < 1.0). For new HIV diagnoses in Black MSM, the highest state-specific disparity was in Wisconsin (RR = 10.12), and the lowest was in Rhode Island (RR = 2.35). For new HIV diagnoses in Hispanic MSM, the highest state-specific disparity was in Pennsylvania (RR = 5.78), and the lowest was in Tennessee (RR = 1.50).
For P&S syphilis diagnoses in Black MSM, the highest state-specific disparity was in Alaska (RR = 17.11), and the lowest was in the District of Columbia (RR = 0.80; 1 of 2 jurisdictions with a Black-White RR < 1.0).
Three of the 6 highest state-specific BlackWhite RRs for HIV diagnoses were in the South; 5 of the 7 highest Hispanic-White disparities for HIV diagnoses occurred in Northeastern states. For Black-White syphilis disparities, 6 of the 7 states with the lowest disparity were Western states. The scatterplots (Figures 1-3 ) illustrated that states with a specific level of disparity can have highly variable patterns of race-specific rates.
DISCUSSION
Health disparity indictors are important indicators of population health and are useful for monitoring the progress of national and state goals to reduce health disparities in the United States. 3 However, measurement of disparities is complex because there is no uniform standard of reporting, and it is particularly complex to calculate rates for hidden populations for which population size may be difficult to ascertain-especially in rural settings. [24] [25] [26] [27] For the first time, to our knowledge, we calculated state-level disparity measures for HIV and syphilis for MSM using state-level disease reports and state-level population-based estimates for MSM. Our analysis allows the discussion of disparities to move beyond national-level disparity measures and allows us to examine the data that are most relevant to state programs, which have primary public health responsibility and authority for disease control and treatment programs. National goals can be met only through the accumulation of many local successes-and these data are intended for state program use and program improvement. Our approach-illustrating the component rates for RRs-has practical implications for health departments and programs. Examining disparities is a key metric for identifying health inequities, and in the case of sexual health, it is clear that Black MSM have the highest rates of HIV and syphilis and the largest disparities compared with White MSM. However, a measure of disparity by itself is not sufficient information to understand how states are doing in HIV prevention and how to focus programmatic and prevention efforts. By plotting the rates of HIV diagnoses in each subgroup and identifying the disparity category, we were able to identify more nuanced understandings of the heterogeneity of MSM's epidemics in states. Across some states, such as North Carolina, Texas, and Oklahoma, HIV diagnosis rates for White MSM are similar, but the HIV diagnosis rates for Black MSM are very different, leading to widely varying RRs on the basis solely of the extent of the differences in rate between these states for Black MSM. The opposite is also true: Iowa, Nevada, and Louisiana have similar HIV rates for Black MSM but widely varying rates among White MSM, leading to broad variation in RRs driven by the differences among states in the White-specific rates.
Florida has a relatively low overall disparity ratio for HIV diagnoses between Black and White MSM but also has the seventh highest state-specific rate of HIV among White MSM. The picture is similar for the comparisons of HIV diagnoses between Hispanic MSM and White MSM: the overall national disparity is reflected in a range of disparity ratios that are greater than 1 in all states with enough data for this measure, but there are multiple race/ethnicity-specific rate scenarios that underlie these summary measures of disparity. For Black-White syphilis ratios ( Figure  3 ), the cluster of states with the lowest disparities (< 2.0) largely represented states with low rates of syphilis for White MSM, with 1 exception: Hawaii, which represented the highest rate of syphilis diagnoses for White MSM.
Other factors associated with low or high disparity are not consistent; for example, 4 of the 5 areas with the lowest Black-White HIV diagnosis disparities (Rhode Island, Oklahoma, Oregon, Colorado) have proportions of Black residents lower than the national average; the fifth area (District of Columbia) has a higher proportion of Black residents than does any US state. The variability in rates among states might be attributable to historical differences in the prevalence of HIV and syphilis overall, to variability in the effectiveness of prevention programs, and to differences in state-level investments in prevention activities. Most states with high HispanicWhite disparities in HIV diagnoses were in the Northeast; this pattern might be related to differences in the country of origin of Hispanics in different US regions and variable prevalence of HIV in those countries of origin. 28 These epidemic patterns translate to public priorities. States such as Arkansas, with high diagnosis rates in Black and White MSM, might consider focusing on examining their overall programmatic response for MSM. But states with high Hispanic-specific rates and low White-specific rates (e.g., Pennsylvania, New York) might consider evaluating existing prevention efforts for Hispanic MSM. States such as Nevada, with the second highest syphilis rate for White MSM and the third highest rate for Black MSM, should examine opportunities for increased syphilis screening and treatment of all MSM. Ultimately, each state has its own patterns of HIV and syphilis rates and disparity ratios, and on the basis of existing state programs, funding, and gaps, each state should develop a tailored program to address both the rates and the disparities. The data we have provided should be useful to states as part of a comprehensive set of data-including surveillance data, program monitoring data, and other state data sourcesto develop a profile of programmatic needs. Data should be provided, with technical assistance, to community planning bodies, local prevention providers, and other stakeholders in HIV and STI prevention programs.
Although these data have programmatic utility, they are subject to limitations. The HIV diagnosis data we used reflect addresses at diagnosis, whereas the MSM denominators reflect current residence and sexual behavior in the previous 5 years. Our syphilis results are limited by heterogeneity in completeness of data on the gender of sexual partner among states and small cell sizes that precluded presentation of Hispanic rates and RRs. Hispanic ethnicity may represent different regional origins in different US states.
The denominator methodology is subject to both random error, which may be considerable in some jurisdictions, and systematic error introduced by key assumptions such as that the race distribution of MSM at the county level reflects that of males generally. Further, because the proportions of men who are MSM vary by state, 16 some states might have apparently higher or lower rates among MSM because of the difference in MSM denominators. Our previous articles have extensively explored these assumptions. 16, 20 Because we combined race and ethnicity for Hispanic men, we were not able to describe some nuances in disparities for Hispanic MSM of varying races. In addition, although these disparities are important to report and follow in an ongoing manner, the actions needed to respond to various patterns of disparities across 2 different diseases is not immediately clear or straightforward. Similar analyses are needed for disparities in other STIs.
We have reported disparity ratios for Black MSM (HIV diagnoses and P&S syphilis) compared with White MSM and for Hispanic MSM (HIV diagnoses only) compared with White MSM for all states with sufficient data to be calculated. We have also reported a novel method of visual depiction of the component race/ethnicity-specific rates to provide further context to the interpretation of the RRs. These data can be updated annually to track progress and see changes in disparities. These data also can be used by states to focus programmatic efforts and to examine the impact of programmatic changes; in the future, data at more granular geographic levels can be developed. State progress in disease rates and disparities will both be needed to reduce HIV and syphilis rates and to meet national prevention goals. 
